Clinical Trials Browser

Colorectal Neoplasms

NCT01138384 2023-08-04

Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer

Phase 1/2 Completed

19 enrolled

Breast

Breast Neoplasms

NCT00952692 2021-12-20

Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer

Phase 1/2 Completed

12 enrolled 9 charts

Breast

Breast Neoplasms

NCT01783756 2019-11-12

Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis

Phase 1/2 Completed

9 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00912275 2019-05-06

Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer

Phase 1/2 Completed

46 enrolled

Breast

Breast Neoplasms

NCT00498953 2018-07-09

Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx

Phase 1/2 Completed

7 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01172223 2016-11-02

LAPADO

Phase 1/2 Completed

81 enrolled

Breast

Breast Neoplasms

NCT00450892 2016-07-07

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Phase 1/2 Completed

129 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00095940 2014-05-23

Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors

Phase 1/2 Completed

52 enrolled 17 charts

CNS

Familial ependymoma, Astrocytoma, Glioblastoma, Medulloblastoma, Oligodendroglioma

NCT00099060 2014-01-27

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 1/2 Completed

24 enrolled

CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01044485 2012-09-25

LapDoc

Phase 1/2 Completed

17 enrolled

Breast

Breast Neoplasms

NCT00316407 2011-02-18

Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients

Phase 1/2 Completed

30 enrolled

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Ovarian Neoplasms

Clinical Trials

M14LTK

Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer

Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer

Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis

Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer

Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx

LAPADO

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

LapDoc

Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients